Concepedia

Debora Malpicci

DM

7

Publications

439

Citations

7

H-Index

2013

Active since

Affiliations

Sapienza University of Rome(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Magna Graecia University

Azienda Ospedaliera Sant'Andrea

Istituti di Ricovero e Cura a Carattere Scientifico

Debora Malpicci is an author at Sapienza University of Rome specializing in health sciences, drug resistance, and tumor heterogeneity.

Top concepts

Publications per year

2013–2019

7

Publications

7

Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells

Alessia Noto, Salvatore Raffa, Claudia De Vitis et al. · Cell Death and Disease · 2013 · 152 citations · Full text

miR-579-3p controls melanoma progression and resistance to target therapy

Luigi Fattore, Rita Mancini, Mario Acunzo et al. · Proceedings of the National Academy of Sciences · 2016 · 114 citations · Full text

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Vera Hirsh, Sandro Pignata, Melissa Bersanelli et al. · Journal of Translational Medicine · 2017 · 43 citations · Full text

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer

Alessia Noto, Claudia De Vitis, Giuseppe Roscilli et al. · Oncotarget · 2013 · 41 citations · Full text

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin

Ciro Francesco Ruggiero, Debora Malpicci, Luigi Fattore et al. · Cancers · 2019 · 36 citations · Full text

, , +17

Rows per page

1–5 of 7